"A spark that lights
the way toward a solution" |
-André Delambre |
|
 |
|
|
|
|
Symposium- Archives |
| Symposium - 2010 |
6th Symposium of the Fondation André-Delambre on Amyotrophic Lateral Sclerosis
Sponsored by the Fondation André-Delambre and now in its sixth year, the Symposium on amyotrophic lateral sclerosis is rapidly becoming one of the top tickets in ALS research. The meeting, held September 24-25 at Université Laval in Québec City, Canada, attracted 80 scientists who discussed cutting-edge data on the mechanisms of the disease and progress on treatments and in the stem cell field. “Speakers presented an avalanche of results that we have to think about,” said Jean-Pierre Julien of Université Laval in a closing statement. Julien co-organized the meeting with Jasna Kriz, also at Laval.
|
 |
| |
| Symposium - 2009 |
5th Symposium of the Fondation André-Delambre on Amyotrophic Lateral Sclerosis
“Researchers need to meet each year to advance the cause of research into ALS.” This was the message of Monica Lalancette, neurologist and researcher at CHU Université Laval, and of Jean-Pierre Julien, a professor at Université Laval. The gathering of experts from around the world became a reality at the 5th Symposium on Amyotrophic Lateral Sclerosis. Some 100 invited guests attended a series of talks on the clinical promise of stem cells, organogenesis and genetics. “The symposium also included students,” Nicolas Dupré, neurologist at Hôpital de l’Enfant-Jésus and associate professor at Université Laval, points out. “It’s a way of encouraging them to consider a career in ALS research, rather than in another field.
|
 |
 |
| |
| Symposium - 2008 |
Montreal, 25-26 September 2008 - Some 150 researchers attended the fourth ALS Symposium of the Fondation André-Delambre at the Montreal Neurological Institute
The fourth Symposium on ALS funded by the Fondation André-Delambre was a success, thanks not only to the number of participants but mostly to the high scientific level of discussions, the participants’ enthusiasm and the quantity of groundbreaking results presented by the speakers. We had two days of intense debates on cutting-edge ALS research. What distinguished this annual symposium from other gatherings was the friendly atmosphere that encouraged exchanges between participants. One of the major outcomes of the symposium was the establishment of new collaborations between participating researchers. We hope that these collaborations will help speed up progress in research and move us closer to the goal of finding a therapeutic cure to stop this terrible disease.
|
 |
|
| Symposium - 2007 |
Approximately 100 research scientists at the Montreal Neurological Institute for the third Symposium on ALS presented by the Fondation André-Delambre (October 4–5, 2007)
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease or Charcot’s disease, is a devastating, incurable disease characterized by a progressive loss of motor neurons, which gradually leads to paralysis and, in most cases, death from respiratory failure within a few years of diagnosis. On October 4 and 5, 2007, the Montreal Neurological Institute hosted the Fondation André-Delambre’s third annual Symposium on ALS.
|
 |
|
| Symposium - 2006 |
Québec,
September 8-9, 2006 – The Fondation André-Delambre’s 2nd Symposium
was a success, not only because of the number of participants
but especially because of the high scientific level of the
discussions, the enthusiasm of the participants and the quantity
of previously unpublished results presented by the speakers.
What makes this annual Symposium stand out is the friendly
atmosphere, which is conducive to dialogue among participants.
Moreover, an important positive effect of the Symposium was
the establishment of several new cooperative ventures among
participating researchers. We hope that these cooperative projects
will allow research to move forward more quickly and get closer
to the objective of finding a therapeutic approach that can
stop this terrible illness.
|
 |
|
| Symposium - 2005 |
Montreal,
August 31, 2005 – The disease has all the
makings of an international assassin; it is known by many names,
it strikes when you least expect it, and most of the people
it touches die. There is no cure for amyotrophic lateral sclerosis
(ALS), known in different countries as Lou Gehrig’s,
Sue Rodriguez’s or Charcot’s disease; sadly, it
kills two to five Canadians a day. The Fondation André Delambre
(FAD) wants this killer stopped and is turning to medical researchers
for help. FAD will sponsor its first international ALS
Symposium September 9 to 10, 2005 at the Montreal Neurological
Institute and Hospital. Scientists from three continents will
convene to discuss causes of the disease and novel approaches
to its treatment including, stem cell and gene therapy.
|
 |
|
| |
| |
|
